(Q74599518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Locoregional treatments of unresectable liver metastases from colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Mario Scartozzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

V Catalano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A M Baldelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N Battelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Graziano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Cellerino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

3-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

Surgical treatment of liver metastases in patients with colorectal cancer

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Resection of liver metastases--when is it worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Improved survival after resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Morbidity and survival of liver resection for colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic cryosurgery in treating colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Cryoablation of unresectable malignant liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Cardiac rhythm disturbances due to caval occlusion during hepatic cryosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

CT of the liver after cryotherapy of hepatic metastases: imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic tumors treated by cryosurgery: normal CT appearance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Liver metastases: results of percutaneous ethanol injection in 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Ethanol injection for the treatment of hepatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

The palliation of hepatic metastases: Results of the radiation therapy oncology group pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

The use of 3-D dose volume analysis to predict radiation hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Combined modality therapy of hepatic metastasis. Northern California Oncology Group Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Response of colo-rectal hepatic metastases to concomitant radiotherapy and intravenous infusion 5 fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Nonabsorbable radioactive material in the treatment of carcinomas by local injections

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

The use of the implantable chemoinfusion pump in the treatment of hepatic metastases of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Regional chemotherapy devices: effect of experience and anatomy on complications

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Regional chemotherapy of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Arterial therapy of hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Evaluation of hepatic dearterialization in primary and secondary cancer of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Improved regional selectivity of hepatic arterial BCNU with degradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Regional Distribution of Diffusible Tracers and Carbonized Microspheres in the Left Ventricle of Isolated Dog Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Starch microsphere-induced arterial flow redistribution after occlusion of replaced hepatic arteries in patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic Artery Ligation and Cytotoxic Infusion in Treatment of Liver Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Effective retreatment of patients with colorectal cancer and liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Indications and therapeutic possibilities using degradable microspheres in liver malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

Chemo-embolization in the treatment of liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2898%2990067-6

7 January 2021

10.1016/S0305-7372(98)90067-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9606364%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference